WHO ICTRP trial
A randomized, double-blind, placebo-controlled clinical trial on the efficacy…
ITMCTR2200006535 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Not Recruiting
Key facts
| Trial ID | ITMCTR2200006535 |
|---|---|
| Public title | A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of matchless yam pills in the treatment of benign prostatic hyperplasia (spleen and kidney deficiency syndrome) |
| Scientific title | A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of matchless yam pills in the treatment of benign prostatic hyperplasia (spleen and kidney deficiency synd |
| Primary sponsor | The Second Affiliated Hospital of Tianjin University of traditional Chinese Medicine |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Prostatic hyperplasia |
| Interventions | treatment group:Incomparable yam pill;control group:Placebo of incomparable yam pills |
| Registration date | Aug 24, 2022 |
| Target size | treatment group:36;control group:36 |
| Secondary IDs | ChiCTR2200062933;ChiMCTR2200006535 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: